Back to Search
SATTVA NEELAPU, M.D.
M.D.
Medical Oncology Physician
NPI: 1386736304IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
M0838(TX)
Education
OTHER
Class of 1991
Research & Publications (20)
Vaccine therapy for B-cell lymphomas: next-generation strategies.
PMID 18024636·Hematology Am Soc Hematol Educ Program·2007
6-review
A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma.
PMID 17339422·Blood·2007
3-trial
Therapeutic lymphoma vaccines: importance of T-cell immunity.
PMID 16827622·Expert Rev Vaccines·2006
6-review
Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma.
PMID 19414675·J Clin Oncol·2009
3-trial
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
PMID 19150940·Ann Oncol·2009
8-other
Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.
PMID 18422783·Br J Haematol·2008
6-review
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
PMID 18411419·Blood·2008
3-trial
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.
PMID 18085611·Cancer·2008
3-trial
A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones.
PMID 17959194·J Immunol Methods·2008
8-other
Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models.
PMID 17933439·Vaccine·2007
7-preclinical
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma.
PMID 17608763·Br J Haematol·2007
3-trial
A novel proteoliposomal vaccine elicits potent antitumor immunity in mice.
PMID 17351111·Blood·2007
7-preclinical
A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy.
PMID 17289891·Clin Cancer Res·2007
8-other
BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.
PMID 17150023·Expert Opin Biol Ther·2007
6-review
Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
PMID 16793161·J Control Release·2006
4-observational
Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera.
PMID 16631194·J Immunol Methods·2006
8-other
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.
PMID 16116429·Nat Med·2005
3-trial
Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report.
PMID 15989711·Clin Lymphoma·2005
3-trial
Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma.
PMID 15968284·Bone Marrow Transplant·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1386736304
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile